WO2006040318A3 - Pi3 kinase gamma inhibitors for the treatment of anaemia - Google Patents
Pi3 kinase gamma inhibitors for the treatment of anaemia Download PDFInfo
- Publication number
- WO2006040318A3 WO2006040318A3 PCT/EP2005/055156 EP2005055156W WO2006040318A3 WO 2006040318 A3 WO2006040318 A3 WO 2006040318A3 EP 2005055156 W EP2005055156 W EP 2005055156W WO 2006040318 A3 WO2006040318 A3 WO 2006040318A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- anaemia
- treatment
- gamma inhibitors
- kinase gamma
- selective
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Priority Applications (10)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2005293556A AU2005293556A1 (en) | 2004-10-12 | 2005-10-11 | PI3 Kinase gamma inhibitors for the treatment of anaemia |
US11/664,969 US20090042773A1 (en) | 2004-10-12 | 2005-10-11 | P13 kinase gamma inhibitors for the treatment of anaemia |
MX2007004302A MX2007004302A (en) | 2004-10-12 | 2005-10-11 | Pi3 kinase gamma inhibitors for the treatment of anaemia. |
CA002580480A CA2580480A1 (en) | 2004-10-12 | 2005-10-11 | Pi3 kinase gamma inhibitors for the treatment of anaemia |
BRPI0517416-3A BRPI0517416A (en) | 2004-10-12 | 2005-10-11 | gamma pi3 kinase inhibitors for treatment of anemia |
EA200700848A EA200700848A1 (en) | 2004-10-12 | 2005-10-11 | PI3-GAMMA KINASE INHIBITORS FOR THE TREATMENT OF ANEMIA |
EP05801722A EP1807075A2 (en) | 2004-10-12 | 2005-10-11 | Pi3 kinase gamma inhibitors for the treatment of anaemia |
JP2007536166A JP2008515955A (en) | 2004-10-12 | 2005-10-11 | PI3 kinase gamma inhibitor for the treatment of anemia |
IL182110A IL182110A0 (en) | 2004-10-12 | 2007-03-22 | P13 kinase gamma inhibitors for the treatment of anemia |
NO20072393A NO20072393L (en) | 2004-10-12 | 2007-05-09 | P13-kinase gamma inhibitors for the treatment of anemia |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP04104997.4 | 2004-10-12 | ||
EP04104997 | 2004-10-12 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2006040318A2 WO2006040318A2 (en) | 2006-04-20 |
WO2006040318A3 true WO2006040318A3 (en) | 2006-08-10 |
Family
ID=34929693
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2005/055156 WO2006040318A2 (en) | 2004-10-12 | 2005-10-11 | Pi3 kinase gamma inhibitors for the treatment of anaemia |
Country Status (14)
Country | Link |
---|---|
US (1) | US20090042773A1 (en) |
EP (1) | EP1807075A2 (en) |
JP (1) | JP2008515955A (en) |
KR (1) | KR20070073857A (en) |
CN (1) | CN101056633A (en) |
AU (1) | AU2005293556A1 (en) |
BR (1) | BRPI0517416A (en) |
CA (1) | CA2580480A1 (en) |
EA (1) | EA200700848A1 (en) |
IL (1) | IL182110A0 (en) |
MX (1) | MX2007004302A (en) |
NO (1) | NO20072393L (en) |
WO (1) | WO2006040318A2 (en) |
ZA (1) | ZA200702435B (en) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ZA200701666B (en) * | 2004-09-03 | 2008-07-30 | Laboratroires Serono Sa | Pyridine méthylène azolidinones and use thereof phospho-inositide inhibitors |
EP2046333A4 (en) * | 2006-07-24 | 2010-09-15 | Glaxosmithkline Llc | Thiozolidinedione derivatives as p13 kinase inhibitors |
JP5561702B2 (en) | 2007-08-02 | 2014-07-30 | アムジエン・インコーポレーテツド | PI3 kinase modulator and method of use |
PE20091268A1 (en) | 2007-12-19 | 2009-09-19 | Amgen Inc | HETEROCYCLIC DERIVATIVES AS PI3 KINASE INHIBITORS |
US8268834B2 (en) | 2008-03-19 | 2012-09-18 | Novartis Ag | Pyrazine derivatives that inhibit phosphatidylinositol 3-kinase enzyme |
US20110172217A1 (en) * | 2008-09-05 | 2011-07-14 | Shionogi & Co., Ltd. | Ring-fused morpholine derivative having pi3k-inhibiting activity |
WO2010110380A1 (en) * | 2009-03-27 | 2010-09-30 | 興和株式会社 | Fused piperidine compound and pharmaceutical agent comprising same |
EP2440556A1 (en) * | 2009-06-10 | 2012-04-18 | Vertex Pharmaceuticals Incorporated | Inhibitors of phosphatidylinositol 3-kinase |
US8633183B2 (en) * | 2010-01-26 | 2014-01-21 | Boehringer Ingelheim International Gmbh | 5-alkynyl-pyrimidines |
US8609672B2 (en) | 2010-08-27 | 2013-12-17 | University Of The Pacific | Piperazinylpyrimidine analogues as protein kinase inhibitors |
CN102584809B (en) * | 2011-01-14 | 2014-12-24 | 湘北威尔曼制药股份有限公司 | Amion thiazolidone compound, method for preparing same and application thereof in preparing antitumor drugs |
US8901145B2 (en) | 2011-04-22 | 2014-12-02 | Jasco Pharmaceuticals, LLC | Aminopyrimidine kinase inhibitors |
JP6215832B2 (en) | 2011-11-04 | 2017-10-18 | ジャスコ ファーマスーティカルズ エルエルシーJasco Pharmaceuticals, LLC | Aminopyrimidine kinase inhibitor |
CR20200286A (en) * | 2011-12-22 | 2020-09-23 | Novartis Ag | Dihydro-benzo-oxazine and dihydro-pyrido-oxazine derivatives |
WO2015162456A1 (en) | 2014-04-24 | 2015-10-29 | Novartis Ag | Amino pyridine derivatives as phosphatidylinositol 3-kinase inhibitors |
US10004732B2 (en) | 2014-04-24 | 2018-06-26 | Novartis Ag | Amino pyrazine derivatives as phosphatidylinositol 3-kinase inhibitors |
MX2016013983A (en) | 2014-04-24 | 2017-04-06 | Novartis Ag | Pyrazine derivatives as phosphatidylinositol 3-kinase inhibitors. |
EA202092490A1 (en) | 2018-04-18 | 2020-12-23 | Констеллейшен Фармасьютикалс, Инк. | METHYL-MODIFYING ENZYMES MODULATORS, COMPOSITIONS AND THEIR APPLICATION |
US11919912B2 (en) | 2018-05-21 | 2024-03-05 | Constellation Pharmaceuticals, Inc. | Modulators of methyl modifying enzymes, compositions and uses thereof |
JPWO2022163843A1 (en) * | 2021-02-01 | 2022-08-04 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004047760A2 (en) * | 2002-11-22 | 2004-06-10 | Smithkline Beecham Corporation | Novel chemical compounds |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW518219B (en) * | 1996-04-26 | 2003-01-21 | Chugai Pharmaceutical Co Ltd | Erythropoietin solution preparation |
BR0312752A (en) * | 2002-07-10 | 2005-04-26 | Applied Research Systems | Azolidinone-vinyl fused benzene derivatives |
-
2005
- 2005-10-11 EP EP05801722A patent/EP1807075A2/en not_active Withdrawn
- 2005-10-11 JP JP2007536166A patent/JP2008515955A/en active Pending
- 2005-10-11 US US11/664,969 patent/US20090042773A1/en not_active Abandoned
- 2005-10-11 CN CNA200580038804XA patent/CN101056633A/en active Pending
- 2005-10-11 WO PCT/EP2005/055156 patent/WO2006040318A2/en active Application Filing
- 2005-10-11 KR KR1020077010007A patent/KR20070073857A/en not_active Application Discontinuation
- 2005-10-11 EA EA200700848A patent/EA200700848A1/en unknown
- 2005-10-11 AU AU2005293556A patent/AU2005293556A1/en not_active Abandoned
- 2005-10-11 ZA ZA200702435A patent/ZA200702435B/en unknown
- 2005-10-11 CA CA002580480A patent/CA2580480A1/en not_active Abandoned
- 2005-10-11 BR BRPI0517416-3A patent/BRPI0517416A/en not_active IP Right Cessation
- 2005-10-11 MX MX2007004302A patent/MX2007004302A/en not_active Application Discontinuation
-
2007
- 2007-03-22 IL IL182110A patent/IL182110A0/en unknown
- 2007-05-09 NO NO20072393A patent/NO20072393L/en not_active Application Discontinuation
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004047760A2 (en) * | 2002-11-22 | 2004-06-10 | Smithkline Beecham Corporation | Novel chemical compounds |
Also Published As
Publication number | Publication date |
---|---|
KR20070073857A (en) | 2007-07-10 |
MX2007004302A (en) | 2007-06-07 |
EA200700848A1 (en) | 2007-10-26 |
CA2580480A1 (en) | 2006-04-20 |
AU2005293556A1 (en) | 2006-04-20 |
JP2008515955A (en) | 2008-05-15 |
CN101056633A (en) | 2007-10-17 |
WO2006040318A2 (en) | 2006-04-20 |
ZA200702435B (en) | 2008-06-25 |
US20090042773A1 (en) | 2009-02-12 |
IL182110A0 (en) | 2007-07-24 |
EP1807075A2 (en) | 2007-07-18 |
BRPI0517416A (en) | 2008-10-07 |
NO20072393L (en) | 2007-05-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2006040318A3 (en) | Pi3 kinase gamma inhibitors for the treatment of anaemia | |
WO2007048064A3 (en) | Amino-pyrimidines as casein kinase ii (ck2) modulators | |
WO2006021884A3 (en) | Enantiomerically pure aminoheteroaryl compounds as protein kinase inhibitors | |
TW200833324A (en) | Sulfonamide derivatives | |
WO2006005609A3 (en) | Substituted oxindol derivatives and medicaments containing the same | |
WO2005118557A3 (en) | Heterocyclic compounds and their use as aldosterone synthase inhibitors | |
WO2007023110A3 (en) | P38 map kinase inhibitors and methods for using the same | |
NO20071593L (en) | pyrimidine | |
TW200626598A (en) | Pyrrazolo-pyrimidine derivatives | |
WO2008017932A3 (en) | Heterocycles useful as inhibitors of carbonic anhydrase | |
WO2007061360A3 (en) | Novel 3-bicyclocarbonylaminopyridine-2-carboxamides or 3-bicyclocarbonylaminopyrazine-2-carboxamides | |
UA94065C2 (en) | Dihydropseudoerythromycin derivatives | |
WO2006005726A3 (en) | Heterocyclic compounds | |
WO2005075425A3 (en) | Substituted bisarylurea derivatives as kinase inhibitors | |
WO2005118541A3 (en) | Heterocyclic compounds and their use as aldosterone synthase inhibitors | |
WO2006116733A3 (en) | Protein kinase inhibitors | |
WO2006000371A3 (en) | Pyrimidine derivatives as 11beta-hsd1 inhibitors | |
GEP20104875B (en) | Pyrimidine derivatives for the treatment of abnormal cell growth | |
WO2007099171A3 (en) | Bicyclo-pyrazoles active as kinase inhibitors | |
WO2007068728A3 (en) | N-substituted pyrrolopyridinones active as kinase inhibitors | |
UA86776C2 (en) | Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof | |
WO2008104473A3 (en) | Pyrazolopyriidine derivatives and their use as kinase inhibitors | |
TW200504029A (en) | Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof | |
TW200626581A (en) | Compounds, compositions containing them, preparation thereof and uses thereof | |
MXPA05013050A (en) | Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KM KP KR KZ LC LK LR LS LT LU LV LY MA MD MG MK MN MW MX MZ NA NG NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU LV MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2580480 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2005293556 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 182110 Country of ref document: IL |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2007/02435 Country of ref document: ZA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2450/DELNP/2007 Country of ref document: IN |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2005801722 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: MX/a/2007/004302 Country of ref document: MX Ref document number: 2007536166 Country of ref document: JP |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
ENP | Entry into the national phase |
Ref document number: 2005293556 Country of ref document: AU Date of ref document: 20051011 Kind code of ref document: A |
|
WWP | Wipo information: published in national office |
Ref document number: 2005293556 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1020077010007 Country of ref document: KR |
|
WWE | Wipo information: entry into national phase |
Ref document number: 200580038804.X Country of ref document: CN |
|
WWE | Wipo information: entry into national phase |
Ref document number: 200700848 Country of ref document: EA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 11664969 Country of ref document: US |
|
WWP | Wipo information: published in national office |
Ref document number: 2005801722 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref document number: PI0517416 Country of ref document: BR |